Cognitive impairment in people with chronic obstructive pulmonary disease (COPD)

Not Applicable

Recruiting

Conditions: cognitive impairment
COPD
Respiratory - Chronic obstructive pulmonary disease
Neurological - Other neurological disorders

Registration Number: ACTRN12618000311257

Lead Sponsor: Dr Lissa Spencer

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 100

Inclusion Criteria

1. Participants will be aged > 40 years and have a diagnosis of COPD [FEV1/FVC: <70%; FEV1% predicted <80% (GOLD Criteria)]
2. Other group will be age matched normal population

Exclusion Criteria

For COPD population: excluded if they have respiratory diseases other than COPD, diagnosis of dementia or unable to read and understand English.
For Age-matched normals: excluded if they have COPD or other respiratory disease, diagnosis of dementia or unable to read and understand English.

Study & Design

Study Type: Observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cognitive Impairment will be assessed using the Montreal Cognitive Assessment (MoCA) <br>The MoCA has been used as a screening instrument for moderate cognitive impairment by assessing memory, language, executive functions, visuospatial skills, calculation, abstraction, attention, concentration and orientation. participants will be asked to answer the questions on the MoCa which will be asked by the physiotherapist.[One time point only at baseline (T1)]

Secondary Outcome Measures